News
NewsPharma Pulse
Academy
Publications
Partner Perspectives
More
Webcasts
Resources
Conferences
Conference CoverageConference Listing
Events
Videos
VideosPeer Exchange
Podcasts
Editorial PodcastsSponsored Podcasts

Subscribe

  • News
  • Academy
  • Publications
  • Partner Perspectives
  • Webcasts
  • Resources
  • Conferences
  • Events
  • Videos
  • Podcasts
  • Subscribe
  • Brand & Product Security
    • Legal & Regulatory
    • Trade & Brand Protection
    • Traceability
  • Business and Finance
  • Cold Chain
    • Containers & Shippers
    • Software
    • Devices
  • Commercial Channels
  • Data & Technology
    • Real World Data
    • Digitalization
    • Artificial Intelligence
  • Logistics & Transportation
    • Manufacturing & Packaging
    • 3PL
    • Supply Chain
  • Market Access
    • Pricing
    • Commercialization
    • Trade & Channel
  • Opinion
  • Patient Support
    • Patient Assistance Programs
    • HUB Services
    • Adherence
Spotlight -
Digital Editions|
Security|
Asembia AXS25 Summit
Advertisement

Mark Hansan and Dr. Scott Howell

Advertisement

Articles by Mark Hansan and Dr. Scott Howell

Image credit: suyujung | stock.adobe.com

In the Shadows of the Drug Affordability Debate, Patients Pay the Ultimate Price

ByMark Hansan and Dr. Scott Howell
January 19th 2024

All healthcare stakeholders must participate to dismantle barriers and ensure access to medicines that save lives.

Advertisement

Latest Updated Articles



    Advertisement
    Advertisement

    Trending on Pharmaceutical Commerce

    1

    The Great Repricing: How Pharma Must Evolve for Three Diverging Payer Economies

    2

    The ROI Moment Pharma Keeps Missing: Point-of-Care as Revenue Protection

    3

    A 'Beautiful Fake': Pharma Fraudsters Upping Their Game

    4

    Trade & Channel Strategies 2025: The $405 Billion Patent Cliff Demands Partnership and Adaptive Market Access Strategies

    5

    Pharma Pulse: ACA Subsidy Gridlock Spurs Cost Crisis, as Lilly’s Retatrutide Delivers Positive Results in Phase III Trial

    • About Us
    • Advertise
    • Editorial
    • Contact Us
    • Do Not Sell My Personal Information
    • Privacy Policy
    • Terms and Conditions
    Contact Info

    259 Prospect Plains Rd, Bldg H
    Cranbury, NJ 08512

    609-716-7777

    Brand Logo

    © 2025 MJH Life Sciences®

    All rights reserved.

    Home
    About Us
    News
    Contact Us